FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2337721883> ?p ?o ?g. }

• W2337721883 endingPage "1990" @default.
• W2337721883 startingPage "1989" @default.
• W2337721883 abstract "Abstract We have re-evaluated the previously reported ability of TLCK-thrombin (N alpha-tosyl-L-lysine chloromethyl ketone-treated alpha-thrombin) and PPACK-thrombin (D-phenylalanyl-L-prolyl-L-arginine chloromethyl ketone- treated alpha-thrombin) to inhibit alpha-thrombin-induced platelet activation (Harmon JT, Jamieson GA: J Biol Chem 261:15928, 1986; and Harmon JT, Jamieson GA: Biochemistry 27:2151, 1988). Despite several cycles of derivatization with TLCK (10,000-fold molar excess), preparations of TLCK-thrombin have been found to contain about 4% residual alpha-thrombin activity, suggesting that these preparations are an equilibrium mixture of TLCK-thrombin and alpha-thrombin and cannot be used for evaluating competition between these two agents. In contrast, alpha-thrombin activity was completely inhibited by PPACK at 15-fold molar excess. PPACK-thrombin, free of unreacted PPACK and devoid of residual alpha-thrombin activity, did not markedly affect platelet shape change at concentrations as high as 1 mumol/L, but inhibited aggregation and secretion in intact platelets activated with the minimal concentration of alpha-thrombin causing a full response (0.3 to 0.5 nmol/L) and yielded a 50% inhibition constant (IC50) for inhibition of aggregation by PPACK-thrombin of 110 nmol/L. This inhibition was specific for alpha-thrombin-induced platelet activation, and no inhibition was seen with activation induced by ADP, collagen, epinephrine, ristocetin, or arachidonate. At these low alpha-thrombin concentrations (approximately 0.4 nmol/L), a persistent cytoplasmic acidification was observed of -0.062 +/- 0.016 pH units, although alkalinization was observed at higher alpha-thrombin concentrations (greater than 1 nmol/L). While inhibition of aggregation and secretion occurred when alpha-thrombin and PPACK-thrombin were added simultaneously, inhibition of cytoplasmic acidification and of the elevation of cytoplasmic [Ca2+] induced by low concentrations of alpha- thrombin (0.4 nmol/L) occurred only if platelets were preincubated with PPACK-thrombin for 5 minutes before the addition of alpha-thrombin. In platelets treated with Serratia marcescens protease to remove glycoprotein lb (GPlb), alpha-thrombin-induced shape change was attenuated but persisted in the presence of a high concentration (2 mumol/L) of PPACK-thrombin, although aggregation and secretion were inhibited, as seen in intact platelets. The IC50 value for inhibition of aggregation by PPACK-thrombin was approximately 1 mumol/L at the higher alpha-thrombin concentrations (5 nmol/L) required for full activation in this case. These results suggest that PPACK-thrombin may be a useful probe of platelet function since it specifically blocks platelet aggregation and secretion induced by alpha-thrombin.(ABSTRACT TRUNCATED AT 400 WORDS)" @default.
• W2337721883 created "2016-06-24" @default.
• W2337721883 creator A5034908430 @default.
• W2337721883 creator A5051164101 @default.
• W2337721883 creator A5055482267 @default.
• W2337721883 creator A5062777059 @default.
• W2337721883 date "1990-05-15" @default.
• W2337721883 modified "2023-09-29" @default.
• W2337721883 title "PPACK-thrombin inhibits thrombin-induced platelet aggregation and cytoplasmic acidification but does not inhibit platelet shape change" @default.
• W2337721883 cites W100011190 @default.
• W2337721883 cites W1007473445 @default.
• W2337721883 cites W1029812605 @default.
• W2337721883 cites W139363061 @default.
• W2337721883 cites W1487192768 @default.
• W2337721883 cites W1492493764 @default.
• W2337721883 cites W1513532364 @default.
• W2337721883 cites W1539155976 @default.
• W2337721883 cites W1549115605 @default.
• W2337721883 cites W1561931582 @default.
• W2337721883 cites W1577019207 @default.
• W2337721883 cites W172079905 @default.
• W2337721883 cites W194357779 @default.
• W2337721883 cites W1946631719 @default.
• W2337721883 cites W1998185507 @default.
• W2337721883 cites W2003155658 @default.
• W2337721883 cites W2016716370 @default.
• W2337721883 cites W2026084719 @default.
• W2337721883 cites W2030328556 @default.
• W2337721883 cites W2041192203 @default.
• W2337721883 cites W2063707452 @default.
• W2337721883 cites W2071572294 @default.
• W2337721883 cites W2087110706 @default.
• W2337721883 cites W2089865447 @default.
• W2337721883 cites W2097908856 @default.
• W2337721883 cites W2106973449 @default.
• W2337721883 cites W2141260882 @default.
• W2337721883 cites W2146217681 @default.
• W2337721883 cites W2224852491 @default.
• W2337721883 cites W2253978746 @default.
• W2337721883 cites W2259617251 @default.
• W2337721883 cites W2273343447 @default.
• W2337721883 cites W2297522537 @default.
• W2337721883 cites W2335901864 @default.
• W2337721883 cites W2399792548 @default.
• W2337721883 cites W2410009650 @default.
• W2337721883 cites W2411775829 @default.
• W2337721883 cites W2418965113 @default.
• W2337721883 cites W45837964 @default.
• W2337721883 cites W2029058842 @default.
• W2337721883 doi "https://doi.org/10.1182/blood.v75.10.1989.1989" @default.
• W2337721883 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2337670" @default.
• W2337721883 hasPublicationYear "1990" @default.
• W2337721883 type Work @default.
• W2337721883 sameAs 2337721883 @default.
• W2337721883 citedByCount "27" @default.
• W2337721883 countsByYear W23377218832016 @default.
• W2337721883 countsByYear W23377218832017 @default.
• W2337721883 countsByYear W23377218832018 @default.
• W2337721883 countsByYear W23377218832022 @default.
• W2337721883 crossrefType "journal-article" @default.
• W2337721883 hasAuthorship W2337721883A5034908430 @default.
• W2337721883 hasAuthorship W2337721883A5051164101 @default.
• W2337721883 hasAuthorship W2337721883A5055482267 @default.
• W2337721883 hasAuthorship W2337721883A5062777059 @default.
• W2337721883 hasConcept C126322002 @default.
• W2337721883 hasConcept C185592680 @default.
• W2337721883 hasConcept C2777292125 @default.
• W2337721883 hasConcept C2778886182 @default.
• W2337721883 hasConcept C3018697912 @default.
• W2337721883 hasConcept C55493867 @default.
• W2337721883 hasConcept C57002609 @default.
• W2337721883 hasConcept C71924100 @default.
• W2337721883 hasConcept C89560881 @default.
• W2337721883 hasConceptScore W2337721883C126322002 @default.
• W2337721883 hasConceptScore W2337721883C185592680 @default.
• W2337721883 hasConceptScore W2337721883C2777292125 @default.
• W2337721883 hasConceptScore W2337721883C2778886182 @default.
• W2337721883 hasConceptScore W2337721883C3018697912 @default.
• W2337721883 hasConceptScore W2337721883C55493867 @default.
• W2337721883 hasConceptScore W2337721883C57002609 @default.
• W2337721883 hasConceptScore W2337721883C71924100 @default.
• W2337721883 hasConceptScore W2337721883C89560881 @default.
• W2337721883 hasIssue "10" @default.
• W2337721883 hasLocation W23377218831 @default.
• W2337721883 hasLocation W23377218832 @default.
• W2337721883 hasOpenAccess W2337721883 @default.
• W2337721883 hasPrimaryLocation W23377218831 @default.
• W2337721883 hasRelatedWork W1977303503 @default.
• W2337721883 hasRelatedWork W1999403270 @default.
• W2337721883 hasRelatedWork W2027876001 @default.
• W2337721883 hasRelatedWork W2031464849 @default.
• W2337721883 hasRelatedWork W2036468924 @default.
• W2337721883 hasRelatedWork W2082860718 @default.
• W2337721883 hasRelatedWork W2084742840 @default.
• W2337721883 hasRelatedWork W2204279058 @default.
• W2337721883 hasRelatedWork W2396678004 @default.
• W2337721883 hasRelatedWork W4296817166 @default.
• W2337721883 hasVolume "75" @default.

• next